Hematopoietic Stem Cells Transplantation Market - Top Companies and Manufacturers

Companies Dominating the Hematopoietic Stem Cells Transplantation Landscape

Lonza Group Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Escape Therapeutics, Inc.
Regen BioPharma, Inc.
ThermoGenesis Holdings, Inc.
CSG-BIO Company, Inc. (CellSave)
CBR Systems, Inc.
Pluristem Inc.
Global Cord Blood Corporation
ViaCord, LLC
Cynata Therapeutics Limited

Browse Key Market Insights with Data Illustration:

Hematopoietic Stem Cells Transplantation Market Size Forecasts 2037

In the News

Lonza Group announced to increase the number of human stem cells it offers by supplying big batch sizes of CD34+ hematopoietic stem cells from human cord blood to expand cohorts for greater capacity and easier HLA-matched model development.
Regen BioPharma, Inc. Announced the introduction of a novel immunotherapy approach using chimeric antigen receptor (CAR) natural killer (NK), macrophage (M), and T cells (T) to overcome the challenges associated with T cell fatigue in existing strategies and enable these cell therapies to successfully target solid tumors.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of hematopoietic stem cells transplantation is evaluated at USD 3.29 billion.

The hematopoietic stem cells transplantation market size was over USD 3.05 billion in 2024 and is expected to exceed USD 10.16 billion by the end of 2037, growing at over 9.7% CAGR during the forecast period i.e., between 2025-2037. Rising prevalence of leukemia and the growing advancements in stem cell transplantation technology will drive the market growth.

North America industry is likely to dominate majority revenue share 40% by 2037, impelled by presence of major key players in the region.

The major players in the market are Escape Therapeutics, Inc., Regen BioPharma, Inc., ThermoGenesis Holdings, Inc., CSG-BIO Company, Inc. (CellSave), CBR Systems, Inc., Pluristem Inc., Global Cord Blood Corporation, ViaCord, LLC, Cynata Therapeutics Limited, and others.

Hematopoietic Stem Cells Transplantation Market - Top Companies and Manufacturers

Companies Dominating the Hematopoietic Stem Cells Transplantation Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the hematopoietic stem cells transplantation market worth?

Why is the demand for hematopoietic stem cells transplantation growing?

Which region dominated the majority of hematopoietic stem cells transplantation industry share?

Who are the top hematopoietic stem cells transplantation companies?